Ad is loading...
ACLX
Price
$87.83
Change
-$7.25 (-7.63%)
Updated
Nov 15 closing price
123 days until earnings call
AUTL
Price
$3.08
Change
+$0.07 (+2.33%)
Updated
Nov 15 closing price
114 days until earnings call
Ad is loading...

ACLX vs AUTL

Header iconACLX vs AUTL Comparison
Open Charts ACLX vs AUTLBanner chart's image
Arcellx
Price$87.83
Change-$7.25 (-7.63%)
Volume$855.37K
CapitalizationN/A
Autolus Therapeutics
Price$3.08
Change+$0.07 (+2.33%)
Volume$2.71M
CapitalizationN/A
ACLX vs AUTL Comparison Chart
Loading...
ACLX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
AUTL
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
ACLX vs. AUTL commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACLX is a Sell and AUTL is a Sell.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (ACLX: $87.83 vs. AUTL: $3.08)
Brand notoriety: ACLX and AUTL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACLX: 148% vs. AUTL: 188%
Market capitalization -- ACLX: $4.75B vs. AUTL: $819.57M
ACLX [@Biotechnology] is valued at $4.75B. AUTL’s [@Biotechnology] market capitalization is $819.57M. The market cap for tickers in the [@Biotechnology] industry ranges from $472.8B to $0. The average market capitalization across the [@Biotechnology] industry is $2.66B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACLX’s FA Score shows that 0 FA rating(s) are green whileAUTL’s FA Score has 0 green FA rating(s).

  • ACLX’s FA Score: 0 green, 5 red.
  • AUTL’s FA Score: 0 green, 5 red.
According to our system of comparison, both ACLX and AUTL are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACLX’s TA Score shows that 3 TA indicator(s) are bullish while AUTL’s TA Score has 4 bullish TA indicator(s).

  • ACLX’s TA Score: 3 bullish, 5 bearish.
  • AUTL’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, both ACLX and AUTL are a bad buy in the short-term.

Price Growth

ACLX (@Biotechnology) experienced а -14.78% price change this week, while AUTL (@Biotechnology) price change was -17.43% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.58%. For the same industry, the average monthly price growth was -5.90%, and the average quarterly price growth was -0.16%.

Reported Earning Dates

ACLX is expected to report earnings on Mar 20, 2025.

AUTL is expected to report earnings on Mar 11, 2025.

Industries' Descriptions

@Biotechnology (-8.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACLX($4.75B) has a higher market cap than AUTL($820M). ACLX YTD gains are higher at: 58.252 vs. AUTL (-52.174). ACLX has higher annual earnings (EBITDA): -46.86M vs. AUTL (-162.54M). AUTL has more cash in the bank: 706M vs. ACLX (517M). AUTL has less debt than ACLX: AUTL (50M) vs ACLX (74.3M). ACLX has higher revenues than AUTL: ACLX (145M) vs AUTL (10.5M).
ACLXAUTLACLX / AUTL
Capitalization4.75B820M579%
EBITDA-46.86M-162.54M29%
Gain YTD58.252-52.174-112%
P/E RatioN/AN/A-
Revenue145M10.5M1,381%
Total Cash517M706M73%
Total Debt74.3M50M149%
FUNDAMENTALS RATINGS
AUTL: Fundamental Ratings
AUTL
OUTLOOK RATING
1..100
63
VALUATION
overvalued / fair valued / undervalued
1..100
41
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
89
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ACLXAUTL
RSI
ODDS (%)
Bearish Trend 3 days ago
75%
Bullish Trend 3 days ago
84%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
86%
Bullish Trend 3 days ago
81%
Momentum
ODDS (%)
Bullish Trend 3 days ago
89%
Bearish Trend 3 days ago
84%
MACD
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
74%
Bearish Trend 3 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
71%
Bearish Trend 3 days ago
86%
Advances
ODDS (%)
Bullish Trend 7 days ago
89%
Bullish Trend 11 days ago
84%
Declines
ODDS (%)
Bearish Trend 3 days ago
75%
Bearish Trend 4 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
78%
Bullish Trend 3 days ago
89%
Aroon
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
80%
View a ticker or compare two or three
Ad is loading...
ACLX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
AUTL
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FSGGX14.93-0.07
-0.47%
Fidelity Global ex US Index
TRPBX25.19-0.18
-0.71%
T. Rowe Price Spectrum Moderate Allc Inv
ENTIX16.11-0.16
-0.98%
ERShares Global Entrepreneurs™ Instl
JICAX77.51-1.11
-1.41%
JPMorgan US Sustainable Leaders A
CSGVX20.72-0.34
-1.61%
Columbia Select Global Equity Advisor

ACLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACLX has been loosely correlated with BEAM. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if ACLX jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACLX
1D Price
Change %
ACLX100%
-7.63%
BEAM - ACLX
49%
Loosely correlated
-8.59%
CRSP - ACLX
48%
Loosely correlated
+0.85%
RCUS - ACLX
47%
Loosely correlated
-0.44%
RCKT - ACLX
47%
Loosely correlated
-5.67%
MGTX - ACLX
47%
Loosely correlated
-2.41%
More

AUTL and

Correlation & Price change

A.I.dvisor indicates that over the last year, AUTL has been loosely correlated with ACLX. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if AUTL jumps, then ACLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AUTL
1D Price
Change %
AUTL100%
+2.33%
ACLX - AUTL
37%
Loosely correlated
-7.63%
CABA - AUTL
36%
Loosely correlated
-19.84%
VCYT - AUTL
36%
Loosely correlated
-2.97%
GOSS - AUTL
34%
Loosely correlated
-3.88%
PLRX - AUTL
34%
Loosely correlated
-3.27%
More